This is consistent with previous data showing the impact of activation of TGR5 signaling in the regulation of hepatic triglyceride homeostasis, which contributes to protection against non-alcoholic fatty liver disease (NAFLD), although the molecular mechanisms have not been elucidated [25]. This evidence concerns the gene GPBAR1 and metabolic dysfunction-associated steatotic liver disease.